Consider Starting a Beta-Blocker for Surgery in High-Risk Patients

October 2014

New Am College of Cardiology and Am Heart Assn guidelines will clarify when to use beta-blockers for noncardiac surgery.

Beta-blockers reduce nonfatal MI risk in high-risk patients undergoing noncardiac surgery...probably by decreasing cardiac workload.

But this benefit can come at a cost...bradycardia, hypotension, and possibly a higher risk of stroke and death.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber Insights: APRN includes:

  • Cutting-edge advice about new medications and how they fit into practice
  • Unbiased, evidence-based, 100% free of financial support from the pharma industry written by your peers
  • Side-by-side comparisons of drugs by class or disease state, plus FAQs, pros/cons, and simple recommendations

Already a subscriber? Log in

Volume pricing available. Get a quote